TrialsgrambetaRCTs are beautiful

Obsessive-compulsive disorder and body dysmorphic disorder: treatment (NICE guideline CG31)

This guideline cites 2 of the 62 landmark trials in our Psychiatry & psychotherapy register.

Issued by
NICE
Year
2005
Source
National Institute for Health and Care Excellence. Obsessive-compulsive disorder and body dysmorphic disorder: treatment. NICE guideline [CG31]. Published 29 November 2005; last reviewed 11 July 2024.

CG31 built a stepped-care model around a single therapeutic core: CBT incorporating exposure and response prevention (ERP), with an SSRI as the pharmacological alternative and the two combined where impairment is severe. Intensity is matched to functional impairment rather than symptom count, and clomipramine remains the second-line drug. It is one of the oldest guidelines still current in this collection; NICE last reviewed it in 2024 without updating it, so the evidence below is thin by design and the 2016 network meta-analysis postdates it.

Exposure and response prevention (adults)1

  • 2005Foa EX/RP Core⁠Psychiatry · OCD · EX/RPIn 122 adults with OCD, intensive exposure and response prevention achieved better response than clomipramine, their combination or pill placebo.Read →

Children & young people1

  • 2004POTS⁠Psychiatry · OCD · PaediatricIn 112 children and adolescents with OCD, CBT alone or combined with sertraline produced higher 12-week remission than sertraline or placebo alone.Read →

Published since the guideline1

  • 2016Skapinakis NMA⁠Psychiatry · OCD · Meta-analysisAcross adults and children with OCD, psychological therapies (chiefly EX/RP) produced larger symptom reduction than each SSRI compared individually.Read →

Cited landmark trials not yet in the register5

Further landmark trials this guideline cites that are not (yet) covered in our register. Each links out to the study for further reading.

Every trial shown is one this guideline actually cites: each link was checked against the guideline's own reference list, and the few that a machine cannot match, a trial cited through a later follow-up, or a NICE guideline, which carries no DOI, were verified by hand against the full text. This is not the guideline's complete reference list, only the landmark trials it cites that our register holds.